Clinical Trial Update: Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports on the use of pentostatin, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia and other B-cell canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia

Drugs mentioned

• Cytoxan (cyclophosphamide)
• NIPENT (pentostatin)
• Rituxan (rituximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED